Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study

D. Campana, Davide Ravizza, P. Ferolla, Antongiulio Faggiano, Franco Grimaldi, Manuela Albertelli, Claudio Ricci, D. Santini, Nicole Brighi, Nicola Fazio, A. Colao, Diego Ferone, P. Tomassetti

Research output: Contribution to journalArticle

Abstract

The aim of this retrospective study was to evaluate the presence of risk factors for a type 1 gastric neuroendocrine neoplasia in a large cohort of patients with chronic atrophic gastritis. The study design consisted of an Italian multicentre, retrospective analysis. The study included all consecutive patients with chronic atrophic gastritis with or without type 1 gastric neuroendocrine neoplasias followed at the participating centres. Two hundred and twenty-nine patients with chronic atrophic gastritis were enroled at the participating centres. A total of 207 patients (154 female, 53 males, median age: 56.0 years) were included in the final analysis. One hundred and twenty-six patients had chronic atrophic gastritis without a gastric neuroendocrine neoplasia and 81 had a chronic atrophic gastritis with type 1 gastric neuroendocrine neoplasia. The median Chromogranin A level, evaluated in 141 patients, was 52.0 U/L. At upper gastrointestinal endoscopy, atrophy of the gastric mucosa was mild/moderate in 137 patients and severe in 68. Intestinal metaplasia of the corpus was present in 168 patients. At histological examination, 81 patients had a gastric neuroendocrine neoplasia (42 patients had a NET G1 and 33 a NET G2). The median Ki67 index was 2.0 %. At univariate and multivariate analysis, the risk factors for a gastric neuroendocrine neoplasia were: male gender, chromogranin A greater than 61 U/L, presence of intestinal metaplasia and age equal to or greater than 59 years. Chromogranin A greater than 61 U/L, the presence of intestinal metaplasia and male gender were independent risk factors for a type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalEndocrine
DOIs
Publication statusAccepted/In press - Sep 3 2016

Keywords

  • Chromogranin A
  • Chronic atrophic gastritis
  • Gastric carcinoid
  • Gastrin
  • Neuroendocrine tumours

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study'. Together they form a unique fingerprint.

  • Cite this

    Campana, D., Ravizza, D., Ferolla, P., Faggiano, A., Grimaldi, F., Albertelli, M., Ricci, C., Santini, D., Brighi, N., Fazio, N., Colao, A., Ferone, D., & Tomassetti, P. (Accepted/In press). Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study. Endocrine, 1-6. https://doi.org/10.1007/s12020-016-1099-y